Resources from the same session
Introduction and scientific background
Presenter: Valentina Guarneri
Session: Controversies in early stage triple negative breast cancer
Resources:
Slides
Webcast
Optimal neo-adjuvant therapy in TNBC: Does one size fit all?
Presenter: Rebecca Dent
Session: Controversies in early stage triple negative breast cancer
Resources:
Slides
Webcast
Individualisation of adjuvant therapy in TNBC: Who gets what?
Presenter: Valentina Guarneri
Session: Controversies in early stage triple negative breast cancer
Resources:
Slides
Webcast
Role of biomarkers / ctDNA monitoring in therapy decisions
Presenter: Aleix Prat
Session: Controversies in early stage triple negative breast cancer
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Controversies in early stage triple negative breast cancer
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Rebecca Dent
Session: Controversies in early stage triple negative breast cancer
Resources:
Webcast